Share Price and Basic Stock Data
Last Updated: February 10, 2026, 9:50 pm
| PEG Ratio | -9.25 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Advance Petrochemicals Ltd operates within the chemicals sector, specifically in the inorganic chemicals segment. The company reported a market capitalization of ₹13.5 Cr and a share price of ₹150. Sales figures have shown a notable increase, rising from ₹27.92 Cr in FY 2022 to ₹37.09 Cr in FY 2023. For FY 2024, sales stood at ₹35.19 Cr, while for FY 2025, they are reported at ₹49.94 Cr, indicating a strong growth trajectory. Quarterly sales data reveals fluctuations, with a peak of ₹12.72 Cr in December 2024, and a decline to ₹7.80 Cr in December 2023. The trailing twelve months (TTM) sales amounted to ₹46.85 Cr, reflecting a robust demand for the company’s products. Despite the ups and downs in the quarterly figures, the overall trend suggests a positive outlook for revenue growth, underscoring the company’s resilience in a competitive market.
Profitability and Efficiency Metrics
Advance Petrochemicals Ltd’s profitability metrics have been under pressure, reflected in a low operating profit margin (OPM) of 2.75% as of the latest report. The operating profit for FY 2025 was ₹1.51 Cr, down from ₹2.76 Cr in FY 2023, showcasing a decline in operational efficiency. The net profit for the same period stood at ₹0.30 Cr, with a net profit margin of 0.60%. The interest coverage ratio (ICR) reported at 2.26x indicates that the company can cover its interest obligations, although it remains a concern given the high P/E ratio of 338, suggesting overvaluation relative to earnings. Return on equity (ROE) at 7.71% and return on capital employed (ROCE) at 9.56% demonstrate adequate returns but are below industry averages, indicating potential inefficiencies in capital utilization. Overall, while the company shows potential through sales growth, its profitability metrics require attention to enhance overall performance.
Balance Sheet Strength and Financial Ratios
Advance Petrochemicals Ltd’s balance sheet reflects a mix of strengths and weaknesses. Total borrowings reached ₹12.72 Cr, compared to reserves of ₹2.91 Cr, which raises concerns about leverage as evidenced by a total debt-to-equity ratio of 2.75. The current ratio stands at 1.02, indicating a near balance between current assets and liabilities, while the quick ratio of 0.67 suggests potential liquidity challenges. Notably, the book value per share increased to ₹43.79, demonstrating a strengthening asset base. The company recorded a cash conversion cycle of 37.41 days, which is efficient compared to industry norms, indicating effective management of working capital. However, the high P/BV ratio of 4.54x indicates that investors are paying a premium for the company’s book value, which may raise concerns about valuation sustainability moving forward.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Advance Petrochemicals Ltd shows a stable commitment from promoters, who hold 50.11% of the shares as of March 2025. This represents a slight increase from previous quarters, reflecting confidence in the company’s long-term potential. The public shareholding stands at 49.89%, with a total of 2,145 shareholders, indicating a broad base of retail investor participation. The stability in promoter shareholding can often signal confidence in corporate governance and long-term strategy, which is crucial for attracting institutional investors. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) suggests a potential gap in institutional interest, which could limit the stock’s liquidity and market perception. Overall, the ownership structure indicates a solid foundation, yet the lack of institutional backing may hinder broader market acceptance.
Outlook, Risks, and Final Insight
Looking ahead, Advance Petrochemicals Ltd faces a dual-edged scenario. On one hand, the upward trend in sales and a stable promoter shareholding provide a foundation for potential growth. However, the company must address profitability challenges, particularly in enhancing its operating margins and managing its debt levels effectively. Risks include the high P/E ratio indicating potential overvaluation and the significant leverage reflected in its debt-to-equity ratio. Moreover, the absence of institutional investor interest may limit future capital raising efforts. To capitalize on growth opportunities, the company could focus on improving operational efficiencies and diversifying its product offerings. In a favorable scenario, successful execution of these strategies could lead to enhanced profitability and investor confidence, while failure to address these issues may result in stagnation or decline in market performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,796 Cr. | 43.4 | 125/33.1 | 70.6 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 13.6 Cr. | 27.2 | 42.9/24.3 | 59.1 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 216 Cr. | 276 | 356/236 | 14.7 | 211 | 2.90 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 7,013 Cr. | 569 | 728/408 | 38.3 | 157 | 0.53 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 348 Cr. | 445 | 494/376 | 14.7 | 144 | 0.67 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,914.38 Cr | 389.29 | 108.64 | 156.25 | 0.49% | 13.95% | 10.65% | 6.18 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.28 | 10.01 | 7.97 | 8.21 | 8.19 | 7.80 | 10.99 | 10.80 | 11.25 | 12.72 | 15.16 | 9.51 | 9.46 |
| Expenses | 8.23 | 9.34 | 7.82 | 8.13 | 7.40 | 7.45 | 10.38 | 10.41 | 11.15 | 12.35 | 14.51 | 9.09 | 9.20 |
| Operating Profit | 1.05 | 0.67 | 0.15 | 0.08 | 0.79 | 0.35 | 0.61 | 0.39 | 0.10 | 0.37 | 0.65 | 0.42 | 0.26 |
| OPM % | 11.31% | 6.69% | 1.88% | 0.97% | 9.65% | 4.49% | 5.55% | 3.61% | 0.89% | 2.91% | 4.29% | 4.42% | 2.75% |
| Other Income | 0.07 | 0.05 | -0.03 | 0.01 | -0.00 | 0.01 | 0.03 | 0.02 | 0.34 | 0.01 | 0.04 | 0.02 | 0.02 |
| Interest | 0.19 | 0.18 | 0.18 | 0.20 | 0.21 | 0.21 | 0.23 | 0.22 | 0.25 | 0.20 | 0.18 | 0.27 | 0.37 |
| Depreciation | 0.12 | 0.12 | 0.43 | 0.20 | 0.20 | 0.20 | 0.10 | 0.17 | 0.17 | 0.17 | 0.08 | 0.15 | 0.15 |
| Profit before tax | 0.81 | 0.42 | -0.49 | -0.31 | 0.38 | -0.05 | 0.31 | 0.02 | 0.02 | 0.01 | 0.43 | 0.02 | -0.24 |
| Tax % | 43.21% | 23.81% | -16.33% | -0.00% | 5.26% | -0.00% | 25.81% | -0.00% | -0.00% | 100.00% | 39.53% | -0.00% | -0.00% |
| Net Profit | 0.46 | 0.31 | -0.41 | -0.31 | 0.37 | -0.05 | 0.23 | 0.01 | 0.02 | -0.00 | 0.27 | 0.01 | -0.24 |
| EPS in Rs | 5.11 | 3.44 | -4.56 | -3.44 | 4.11 | -0.56 | 2.56 | 0.11 | 0.22 | -0.00 | 3.00 | 0.11 | -2.67 |
Last Updated: February 3, 2026, 9:46 am
Below is a detailed analysis of the quarterly data for Advance Petrochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 9.46 Cr.. The value appears to be declining and may need further review. It has decreased from 9.51 Cr. (Jun 2025) to 9.46 Cr., marking a decrease of 0.05 Cr..
- For Expenses, as of Sep 2025, the value is 9.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.09 Cr. (Jun 2025) to 9.20 Cr., marking an increase of 0.11 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.26 Cr.. The value appears to be declining and may need further review. It has decreased from 0.42 Cr. (Jun 2025) to 0.26 Cr., marking a decrease of 0.16 Cr..
- For OPM %, as of Sep 2025, the value is 2.75%. The value appears to be declining and may need further review. It has decreased from 4.42% (Jun 2025) to 2.75%, marking a decrease of 1.67%.
- For Other Income, as of Sep 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.02 Cr..
- For Interest, as of Sep 2025, the value is 0.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.27 Cr. (Jun 2025) to 0.37 Cr., marking an increase of 0.10 Cr..
- For Depreciation, as of Sep 2025, the value is 0.15 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.15 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.24 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Jun 2025) to -0.24 Cr., marking a decrease of 0.26 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -0.24 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Jun 2025) to -0.24 Cr., marking a decrease of 0.25 Cr..
- For EPS in Rs, as of Sep 2025, the value is -2.67. The value appears to be declining and may need further review. It has decreased from 0.11 (Jun 2025) to -2.67, marking a decrease of 2.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:18 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.54 | 11.20 | 10.46 | 8.85 | 12.74 | 21.29 | 13.90 | 17.44 | 27.92 | 37.09 | 35.19 | 49.94 | 46.85 |
| Expenses | 12.00 | 10.42 | 9.62 | 7.97 | 11.90 | 20.31 | 12.99 | 16.25 | 26.42 | 34.33 | 33.36 | 48.43 | 45.15 |
| Operating Profit | 0.54 | 0.78 | 0.84 | 0.88 | 0.84 | 0.98 | 0.91 | 1.19 | 1.50 | 2.76 | 1.83 | 1.51 | 1.70 |
| OPM % | 4.31% | 6.96% | 8.03% | 9.94% | 6.59% | 4.60% | 6.55% | 6.82% | 5.37% | 7.44% | 5.20% | 3.02% | 3.63% |
| Other Income | 0.18 | 0.01 | 0.03 | 0.03 | 0.08 | 0.09 | 0.10 | 0.12 | 0.06 | 0.09 | 0.06 | 0.41 | 0.09 |
| Interest | 0.40 | 0.45 | 0.53 | 0.58 | 0.64 | 0.77 | 0.77 | 0.72 | 0.72 | 0.74 | 0.88 | 0.85 | 1.02 |
| Depreciation | 0.13 | 0.20 | 0.19 | 0.18 | 0.18 | 0.19 | 0.17 | 0.22 | 0.40 | 0.79 | 0.70 | 0.60 | 0.55 |
| Profit before tax | 0.19 | 0.14 | 0.15 | 0.15 | 0.10 | 0.11 | 0.07 | 0.37 | 0.44 | 1.32 | 0.31 | 0.47 | 0.22 |
| Tax % | 36.84% | 64.29% | 53.33% | 46.67% | 10.00% | 0.00% | 0.00% | 27.03% | 31.82% | 28.03% | 32.26% | 36.17% | |
| Net Profit | 0.12 | 0.06 | 0.07 | 0.09 | 0.08 | 0.11 | 0.07 | 0.28 | 0.30 | 0.94 | 0.22 | 0.30 | 0.04 |
| EPS in Rs | 1.33 | 0.67 | 0.78 | 1.00 | 0.89 | 1.22 | 0.78 | 3.11 | 3.33 | 10.44 | 2.44 | 3.33 | 0.44 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 16.67% | 28.57% | -11.11% | 37.50% | -36.36% | 300.00% | 7.14% | 213.33% | -76.60% | 36.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | 66.67% | 11.90% | -39.68% | 48.61% | -73.86% | 336.36% | -292.86% | 206.19% | -289.93% | 112.96% |
Advance Petrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 29% |
| 3 Years: | 21% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 34% |
| 3 Years: | -4% |
| TTM: | -46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 37% |
| 3 Years: | 27% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 2:06 pm
Balance Sheet
Last Updated: December 10, 2025, 3:45 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 |
| Reserves | 0.63 | 0.68 | 0.75 | 0.84 | 0.92 | 1.03 | 1.10 | 1.38 | 1.67 | 2.62 | 2.84 | 3.14 | 2.91 |
| Borrowings | 3.40 | 4.34 | 5.24 | 5.01 | 6.27 | 6.38 | 6.63 | 7.36 | 6.98 | 7.18 | 8.98 | 10.85 | 12.72 |
| Other Liabilities | 2.07 | 2.17 | 1.51 | 1.84 | 2.61 | 3.25 | 2.08 | 3.14 | 5.89 | 5.02 | 9.94 | 10.45 | 6.34 |
| Total Liabilities | 7.00 | 8.09 | 8.40 | 8.59 | 10.70 | 11.56 | 10.71 | 12.78 | 15.44 | 15.72 | 22.66 | 25.34 | 22.87 |
| Fixed Assets | 1.57 | 1.82 | 1.91 | 1.79 | 2.06 | 1.81 | 1.65 | 2.65 | 3.45 | 5.00 | 5.76 | 5.17 | 4.88 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.48 | 0.00 | 0.00 | 0.43 | 0.00 | 2.49 | 3.42 |
| Investments | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.00 |
| Other Assets | 5.07 | 5.91 | 6.13 | 6.19 | 8.28 | 9.39 | 8.22 | 9.77 | 11.63 | 9.93 | 16.54 | 17.32 | 14.57 |
| Total Assets | 7.00 | 8.09 | 8.40 | 8.59 | 10.70 | 11.56 | 10.71 | 12.78 | 15.44 | 15.72 | 22.66 | 25.34 | 22.87 |
Below is a detailed analysis of the balance sheet data for Advance Petrochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 0.90 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.90 Cr..
- For Reserves, as of Sep 2025, the value is 2.91 Cr.. The value appears to be declining and may need further review. It has decreased from 3.14 Cr. (Mar 2025) to 2.91 Cr., marking a decrease of 0.23 Cr..
- For Borrowings, as of Sep 2025, the value is 12.72 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 10.85 Cr. (Mar 2025) to 12.72 Cr., marking an increase of 1.87 Cr..
- For Other Liabilities, as of Sep 2025, the value is 6.34 Cr.. The value appears to be improving (decreasing). It has decreased from 10.45 Cr. (Mar 2025) to 6.34 Cr., marking a decrease of 4.11 Cr..
- For Total Liabilities, as of Sep 2025, the value is 22.87 Cr.. The value appears to be improving (decreasing). It has decreased from 25.34 Cr. (Mar 2025) to 22.87 Cr., marking a decrease of 2.47 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4.88 Cr.. The value appears to be declining and may need further review. It has decreased from 5.17 Cr. (Mar 2025) to 4.88 Cr., marking a decrease of 0.29 Cr..
- For CWIP, as of Sep 2025, the value is 3.42 Cr.. The value appears strong and on an upward trend. It has increased from 2.49 Cr. (Mar 2025) to 3.42 Cr., marking an increase of 0.93 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.36 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.36 Cr..
- For Other Assets, as of Sep 2025, the value is 14.57 Cr.. The value appears to be declining and may need further review. It has decreased from 17.32 Cr. (Mar 2025) to 14.57 Cr., marking a decrease of 2.75 Cr..
- For Total Assets, as of Sep 2025, the value is 22.87 Cr.. The value appears to be declining and may need further review. It has decreased from 25.34 Cr. (Mar 2025) to 22.87 Cr., marking a decrease of 2.47 Cr..
However, the Borrowings (12.72 Cr.) are higher than the Reserves (2.91 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -2.86 | -3.56 | -4.40 | -4.13 | -5.43 | -5.40 | -5.72 | -6.17 | -5.48 | -4.42 | -7.15 | -9.34 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61.71 | 73.98 | 80.26 | 51.97 | 53.00 | 41.83 | 32.30 | 53.16 | 63.93 | 35.92 | 93.56 | 70.97 |
| Inventory Days | 77.37 | 118.64 | 135.92 | 271.87 | 226.41 | 127.25 | 217.07 | 185.97 | 111.70 | 76.07 | 89.34 | 53.73 |
| Days Payable | 38.87 | 49.55 | 34.11 | 98.61 | 89.06 | 61.39 | 56.50 | 75.02 | 100.40 | 57.52 | 131.91 | 87.28 |
| Cash Conversion Cycle | 100.21 | 143.07 | 182.07 | 225.22 | 190.35 | 107.69 | 192.87 | 164.11 | 75.23 | 54.46 | 50.98 | 37.41 |
| Working Capital Days | 25.32 | 22.81 | 20.24 | 29.69 | 25.78 | 11.66 | 13.39 | 13.19 | 3.53 | -5.90 | 0.93 | -2.12 |
| ROCE % | 11.52% | 10.88% | 10.62% | 10.70% | 9.97% | 10.73% | 9.92% | 11.82% | 12.61% | 20.35% | 10.16% | 9.56% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| Diluted EPS (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| Cash EPS (Rs.) | 10.00 | 10.12 | 19.28 | 7.75 | 5.51 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 43.79 | 40.43 | 38.03 | 27.54 | 24.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 44.86 | 41.50 | 39.10 | 28.61 | 25.32 |
| Revenue From Operations / Share (Rs.) | 554.84 | 390.97 | 412.12 | 310.20 | 193.80 |
| PBDIT / Share (Rs.) | 21.39 | 20.96 | 31.64 | 17.29 | 14.57 |
| PBIT / Share (Rs.) | 14.75 | 13.24 | 22.85 | 12.82 | 12.15 |
| PBT / Share (Rs.) | 5.28 | 3.48 | 14.62 | 4.84 | 4.17 |
| Net Profit / Share (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| PBDIT Margin (%) | 3.85 | 5.36 | 7.67 | 5.57 | 7.51 |
| PBIT Margin (%) | 2.65 | 3.38 | 5.54 | 4.13 | 6.26 |
| PBT Margin (%) | 0.95 | 0.88 | 3.54 | 1.56 | 2.15 |
| Net Profit Margin (%) | 0.60 | 0.61 | 2.54 | 1.05 | 1.59 |
| Return on Networth / Equity (%) | 7.66 | 5.93 | 27.59 | 11.92 | 12.76 |
| Return on Capital Employeed (%) | 15.20 | 16.84 | 35.07 | 24.49 | 21.89 |
| Return On Assets (%) | 1.19 | 0.95 | 6.00 | 1.91 | 2.17 |
| Long Term Debt / Equity (X) | 1.09 | 0.82 | 0.59 | 0.73 | 1.12 |
| Total Debt / Equity (X) | 2.75 | 2.47 | 2.10 | 2.75 | 3.36 |
| Asset Turnover Ratio (%) | 2.08 | 1.83 | 2.38 | 1.98 | 1.48 |
| Current Ratio (X) | 1.02 | 1.05 | 0.98 | 1.07 | 1.17 |
| Quick Ratio (X) | 0.67 | 0.65 | 0.45 | 0.52 | 0.40 |
| Inventory Turnover Ratio (X) | 8.29 | 6.18 | 4.37 | 3.22 | 2.10 |
| Interest Coverage Ratio (X) | 2.26 | 2.15 | 3.85 | 2.17 | 1.83 |
| Interest Coverage Ratio (Post Tax) (X) | 1.35 | 1.25 | 2.28 | 1.41 | 1.39 |
| Enterprise Value (Cr.) | 28.04 | 25.00 | 48.28 | 10.15 | 10.42 |
| EV / Net Operating Revenue (X) | 0.56 | 0.71 | 1.30 | 0.36 | 0.59 |
| EV / EBITDA (X) | 14.56 | 13.25 | 16.96 | 6.52 | 7.95 |
| MarketCap / Net Operating Revenue (X) | 0.35 | 0.47 | 1.12 | 0.13 | 0.19 |
| Price / BV (X) | 4.54 | 4.58 | 12.15 | 1.52 | 1.59 |
| Price / Net Operating Revenue (X) | 0.35 | 0.47 | 1.12 | 0.13 | 0.19 |
| EarningsYield | 0.01 | 0.01 | 0.02 | 0.07 | 0.08 |
After reviewing the key financial ratios for Advance Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.00. This value is within the healthy range. It has decreased from 10.12 (Mar 24) to 10.00, marking a decrease of 0.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 43.79. It has increased from 40.43 (Mar 24) to 43.79, marking an increase of 3.36.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 44.86. It has increased from 41.50 (Mar 24) to 44.86, marking an increase of 3.36.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 554.84. It has increased from 390.97 (Mar 24) to 554.84, marking an increase of 163.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 21.39. This value is within the healthy range. It has increased from 20.96 (Mar 24) to 21.39, marking an increase of 0.43.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.75. This value is within the healthy range. It has increased from 13.24 (Mar 24) to 14.75, marking an increase of 1.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.28. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 5.28, marking an increase of 1.80.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.36. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For PBDIT Margin (%), as of Mar 25, the value is 3.85. This value is below the healthy minimum of 10. It has decreased from 5.36 (Mar 24) to 3.85, marking a decrease of 1.51.
- For PBIT Margin (%), as of Mar 25, the value is 2.65. This value is below the healthy minimum of 10. It has decreased from 3.38 (Mar 24) to 2.65, marking a decrease of 0.73.
- For PBT Margin (%), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 10. It has increased from 0.88 (Mar 24) to 0.95, marking an increase of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 0.61 (Mar 24) to 0.60, marking a decrease of 0.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.66. This value is below the healthy minimum of 15. It has increased from 5.93 (Mar 24) to 7.66, marking an increase of 1.73.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.20. This value is within the healthy range. It has decreased from 16.84 (Mar 24) to 15.20, marking a decrease of 1.64.
- For Return On Assets (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 5. It has increased from 0.95 (Mar 24) to 1.19, marking an increase of 0.24.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 1.09. This value exceeds the healthy maximum of 1. It has increased from 0.82 (Mar 24) to 1.09, marking an increase of 0.27.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.75. This value exceeds the healthy maximum of 1. It has increased from 2.47 (Mar 24) to 2.75, marking an increase of 0.28.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.83 (Mar 24) to 2.08, marking an increase of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 1.02. This value is below the healthy minimum of 1.5. It has decreased from 1.05 (Mar 24) to 1.02, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.67, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.29. This value exceeds the healthy maximum of 8. It has increased from 6.18 (Mar 24) to 8.29, marking an increase of 2.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has increased from 2.15 (Mar 24) to 2.26, marking an increase of 0.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 3. It has increased from 1.25 (Mar 24) to 1.35, marking an increase of 0.10.
- For Enterprise Value (Cr.), as of Mar 25, the value is 28.04. It has increased from 25.00 (Mar 24) to 28.04, marking an increase of 3.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.56, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 14.56. This value is within the healthy range. It has increased from 13.25 (Mar 24) to 14.56, marking an increase of 1.31.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
- For Price / BV (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has decreased from 4.58 (Mar 24) to 4.54, marking a decrease of 0.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Advance Petrochemicals Ltd:
- Net Profit Margin: 0.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.2% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.66% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.35
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.67
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 308 (Industry average Stock P/E: 108.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.75
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.6%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | 36, Kothari Market, Kankaria Road, Ahmedabad Gujarat 380022 | info@advancepetro.com http://www.advancepetro.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pulkit Goenka | Chairman & Managing Director |
| Ms. Aanchal Arvind Goenka | Non Executive Woman Director |
| Mr. Akshat Shukla | Non Exe. & Ind. Director |
| Mr. Arvind Vishwanath Goenka | Non Executive Director |
| Mrs. Palak Tapas Relia | Non Executive Woman Director |
| Mr. Harshil B Vadodariya | Non Exe. & Ind. Director |
FAQ
What is the intrinsic value of Advance Petrochemicals Ltd?
Advance Petrochemicals Ltd's intrinsic value (as of 11 February 2026) is ₹546.81 which is 299.13% higher the current market price of ₹137.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹12.3 Cr. market cap, FY2025-2026 high/low of ₹242/130, reserves of ₹2.91 Cr, and liabilities of ₹22.87 Cr.
What is the Market Cap of Advance Petrochemicals Ltd?
The Market Cap of Advance Petrochemicals Ltd is 12.3 Cr..
What is the current Stock Price of Advance Petrochemicals Ltd as on 11 February 2026?
The current stock price of Advance Petrochemicals Ltd as on 11 February 2026 is ₹137.
What is the High / Low of Advance Petrochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Advance Petrochemicals Ltd stocks is ₹242/130.
What is the Stock P/E of Advance Petrochemicals Ltd?
The Stock P/E of Advance Petrochemicals Ltd is 308.
What is the Book Value of Advance Petrochemicals Ltd?
The Book Value of Advance Petrochemicals Ltd is 42.3.
What is the Dividend Yield of Advance Petrochemicals Ltd?
The Dividend Yield of Advance Petrochemicals Ltd is 0.00 %.
What is the ROCE of Advance Petrochemicals Ltd?
The ROCE of Advance Petrochemicals Ltd is 9.56 %.
What is the ROE of Advance Petrochemicals Ltd?
The ROE of Advance Petrochemicals Ltd is 7.71 %.
What is the Face Value of Advance Petrochemicals Ltd?
The Face Value of Advance Petrochemicals Ltd is 10.0.